145 related articles for article (PubMed ID: 19016747)
1. Inhibition of peroxisome proliferator-activated receptor gamma activity suppresses pancreatic cancer cell motility.
Nakajima A; Tomimoto A; Fujita K; Sugiyama M; Takahashi H; Ikeda I; Hosono K; Endo H; Yoneda K; Iida H; Inamori M; Kubota K; Saito S; Nakajima N; Wada K; Nagashima Y; Nakagama H
Cancer Sci; 2008 Oct; 99(10):1892-900. PubMed ID: 19016747
[TBL] [Abstract][Full Text] [Related]
2. Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition.
Dong YW; Wang XP; Wu K
World J Gastroenterol; 2009 Jan; 15(4):441-8. PubMed ID: 19152448
[TBL] [Abstract][Full Text] [Related]
3. Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases.
Taniuchi K; Nakagawa H; Hosokawa M; Nakamura T; Eguchi H; Ohigashi H; Ishikawa O; Katagiri T; Nakamura Y
Cancer Res; 2005 Apr; 65(8):3092-9. PubMed ID: 15833838
[TBL] [Abstract][Full Text] [Related]
4. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
[TBL] [Abstract][Full Text] [Related]
5. PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells.
Schaefer KL; Takahashi H; Morales VM; Harris G; Barton S; Osawa E; Nakajima A; Saubermann LJ
Int J Cancer; 2007 Feb; 120(3):702-13. PubMed ID: 17096328
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-γ inhibits pancreatic cancer cell invasion and metastasis via regulating MMP-2 expression through PTEN.
Li Y; Zhang DW; Lin DQ; Cao LQ
Mol Med Rep; 2015 Oct; 12(4):6255-60. PubMed ID: 26299428
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
Magenta G; Borenstein X; Rolando R; Jasnis MA
BMC Cancer; 2008 Feb; 8():47. PubMed ID: 18261208
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes.
Ramirez SH; Heilman D; Morsey B; Potula R; Haorah J; Persidsky Y
J Immunol; 2008 Feb; 180(3):1854-65. PubMed ID: 18209083
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms.
Elix CC; Salgia MM; Otto-Duessel M; Copeland BT; Yoo C; Lee M; Tew BY; Ann D; Pal SK; Jones JO
Prostate; 2020 Feb; 80(2):162-172. PubMed ID: 31769890
[TBL] [Abstract][Full Text] [Related]
10. Rac1 and Cdc42 differentially modulate cigarette smoke-induced airway cell migration through p120-catenin-dependent and -independent pathways.
Zhang L; Gallup M; Zlock L; Finkbeiner WE; McNamara NA
Am J Pathol; 2013 Jun; 182(6):1986-95. PubMed ID: 23562274
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells.
Schaefer KL; Wada K; Takahashi H; Matsuhashi N; Ohnishi S; Wolfe MM; Turner JR; Nakajima A; Borkan SC; Saubermann LJ
Cancer Res; 2005 Mar; 65(6):2251-9. PubMed ID: 15781638
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
Fujita M; Hasegawa A; Yamamori M; Okamura N
J Exp Clin Cancer Res; 2017 Jul; 36(1):91. PubMed ID: 28673319
[TBL] [Abstract][Full Text] [Related]
13. PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells.
Koga H; Selvendiran K; Sivakumar R; Yoshida T; Torimura T; Ueno T; Sata M
Int J Oncol; 2012 Mar; 40(3):679-85. PubMed ID: 22020928
[TBL] [Abstract][Full Text] [Related]
14. HER2/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42.
Johnson E; Seachrist DD; DeLeon-Rodriguez CM; Lozada KL; Miedler J; Abdul-Karim FW; Keri RA
J Biol Chem; 2010 Sep; 285(38):29491-501. PubMed ID: 20595387
[TBL] [Abstract][Full Text] [Related]
15. Critical role of peroxisome proliferator-activated receptor gamma on anoikis and invasion of squamous cell carcinoma.
Masuda T; Wada K; Nakajima A; Okura M; Kudo C; Kadowaki T; Kogo M; Kamisaki Y
Clin Cancer Res; 2005 Jun; 11(11):4012-21. PubMed ID: 15930335
[TBL] [Abstract][Full Text] [Related]
16. [Regulatory effects of peroxisome proliferator-activated receptor gamma on the growth of pancreatic carcinoma].
Dong YW; Wang XP; Wu K; Wu LY; Zhang RL
Zhonghua Nei Ke Za Zhi; 2003 Jul; 42(7):479-82. PubMed ID: 12921608
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor γ agonist efatutazone impairs transforming growth factor β2-induced motility of epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer cells.
Serizawa M; Murakami H; Watanabe M; Takahashi T; Yamamoto N; Koh Y
Cancer Sci; 2014 Jun; 105(6):683-9. PubMed ID: 24698130
[TBL] [Abstract][Full Text] [Related]
18. The PPARgamma antagonist T0070907 suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms.
Zaytseva YY; Wallis NK; Southard RC; Kilgore MW
Anticancer Res; 2011 Mar; 31(3):813-23. PubMed ID: 21498701
[TBL] [Abstract][Full Text] [Related]
19. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo.
Itami A; Watanabe G; Shimada Y; Hashimoto Y; Kawamura J; Kato M; Hosotani R; Imamura M
Int J Cancer; 2001 Nov; 94(3):370-6. PubMed ID: 11745416
[TBL] [Abstract][Full Text] [Related]
20. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
